Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus.

PubWeight™: 7.27‹?› | Rank: Top 1%

🔗 View Article (PMC 238023)

Published in J Virol on October 01, 1993

Authors

D Naniche1, G Varior-Krishnan, F Cervoni, T F Wild, B Rossi, C Rabourdin-Combe, D Gerlier

Author Affiliations

1: CNRS-ENS-Lyon UMR 49, France.

Articles citing this

(truncated to the top 100)

Rescue of measles viruses from cloned DNA. EMBO J (1995) 7.87

Complement evasion by human pathogens. Nat Rev Microbiol (2008) 4.24

Measles viruses with altered envelope protein cytoplasmic tails gain cell fusion competence. J Virol (1998) 3.27

Measles viruses on throat swabs from measles patients use signaling lymphocytic activation molecule (CDw150) but not CD46 as a cellular receptor. J Virol (2001) 3.27

Ephrin-B2 ligand is a functional receptor for Hendra virus and Nipah virus. Proc Natl Acad Sci U S A (2005) 3.18

Reprogrammed viruses as cancer therapeutics: targeted, armed and shielded. Nat Rev Microbiol (2008) 3.01

Virus receptors: binding, adhesion strengthening, and changes in viral structure. J Virol (1994) 2.92

Measles virus suppresses cell-mediated immunity by interfering with the survival and functions of dendritic and T cells. J Exp Med (1997) 2.90

Measles virus spread and pathogenesis in genetically modified mice. J Virol (1998) 2.84

Tumor cell marker PVRL4 (nectin 4) is an epithelial cell receptor for measles virus. PLoS Pathog (2011) 2.74

Crystal structure of measles virus hemagglutinin provides insight into effective vaccines. Proc Natl Acad Sci U S A (2007) 2.56

Selectively receptor-blind measles viruses: Identification of residues necessary for SLAM- or CD46-induced fusion and their localization on a new hemagglutinin structural model. J Virol (2004) 2.42

Measles virus structural components are enriched into lipid raft microdomains: a potential cellular location for virus assembly. J Virol (2000) 2.40

Coxsackievirus B3 adapted to growth in RD cells binds to decay-accelerating factor (CD55). J Virol (1995) 2.31

Update on human herpesvirus 6 biology, clinical features, and therapy. Clin Microbiol Rev (2005) 2.24

Measles virus blind to its epithelial cell receptor remains virulent in rhesus monkeys but cannot cross the airway epithelium and is not shed. J Clin Invest (2008) 2.21

Identification of two amino acids in the hemagglutinin glycoprotein of measles virus (MV) that govern hemadsorption, HeLa cell fusion, and CD46 downregulation: phenotypic markers that differentiate vaccine and wild-type MV strains. J Virol (1996) 2.19

SLAM (CD150)-independent measles virus entry as revealed by recombinant virus expressing green fluorescent protein. J Virol (2002) 2.09

Multiple isoforms of CD46 (membrane cofactor protein) serve as receptors for measles virus. Proc Natl Acad Sci U S A (1994) 2.08

Strength of envelope protein interaction modulates cytopathicity of measles virus. J Virol (2002) 1.97

CD150 (SLAM) is a receptor for measles virus but is not involved in viral contact-mediated proliferation inhibition. J Virol (2001) 1.94

Receptor usage and differential downregulation of CD46 by measles virus wild-type and vaccine strains. Proc Natl Acad Sci U S A (1995) 1.89

Interaction of measles virus glycoproteins with the surface of uninfected peripheral blood lymphocytes induces immunosuppression in vitro. Proc Natl Acad Sci U S A (1996) 1.89

A single amino acid change in the hemagglutinin protein of measles virus determines its ability to bind CD46 and reveals another receptor on marmoset B cells. J Virol (1998) 1.88

The hemagglutinin of canine distemper virus determines tropism and cytopathogenicity. J Virol (2001) 1.88

Membrane cofactor protein (CD46) is a keratinocyte receptor for the M protein of the group A streptococcus. Proc Natl Acad Sci U S A (1995) 1.86

Structure of the measles virus hemagglutinin bound to its cellular receptor SLAM. Nat Struct Mol Biol (2011) 1.85

Induction of maturation of human blood dendritic cell precursors by measles virus is associated with immunosuppression. Proc Natl Acad Sci U S A (1997) 1.85

Tropism illuminated: lymphocyte-based pathways blazed by lethal morbillivirus through the host immune system. Proc Natl Acad Sci U S A (2004) 1.84

Common variants associated with general and MMR vaccine-related febrile seizures. Nat Genet (2014) 1.81

Early target cells of measles virus after aerosol infection of non-human primates. PLoS Pathog (2011) 1.80

Functional interaction between paramyxovirus fusion and attachment proteins. J Biol Chem (2008) 1.78

Four viruses, two bacteria, and one receptor: membrane cofactor protein (CD46) as pathogens' magnet. J Virol (2004) 1.78

Membrane cofactor protein is a receptor for adenoviruses associated with epidemic keratoconjunctivitis. J Virol (2004) 1.77

Decay-accelerating factor CD55 is identified as the receptor for echovirus 7 using CELICS, a rapid immuno-focal cloning method. EMBO J (1994) 1.76

Mouse complement regulatory protein Crry/p65 uses the specific mechanisms of both human decay-accelerating factor and membrane cofactor protein. J Exp Med (1995) 1.74

Crystal structure of two CD46 domains reveals an extended measles virus-binding surface. EMBO J (1999) 1.73

Clinical isolates of measles virus use CD46 as a cellular receptor. J Virol (2000) 1.72

Applications of flow cytometry to clinical microbiology. Clin Microbiol Rev (2000) 1.69

Sequence and structure alignment of Paramyxoviridae attachment proteins and discovery of enzymatic activity for a morbillivirus hemagglutinin. J Virol (1997) 1.67

Measles virus and C3 binding sites are distinct on membrane cofactor protein (CD46). Proc Natl Acad Sci U S A (1995) 1.64

Measles virus infects both polarized epithelial and immune cells by using distinctive receptor-binding sites on its hemagglutinin. J Virol (2008) 1.62

A transgenic mouse model for measles virus infection of the brain. Proc Natl Acad Sci U S A (1997) 1.62

Identification of Hendra virus G glycoprotein residues that are critical for receptor binding. J Virol (2007) 1.61

Measles virus infection of thymic epithelium in the SCID-hu mouse leads to thymocyte apoptosis. J Virol (1996) 1.61

The heads of the measles virus attachment protein move to transmit the fusion-triggering signal. Nat Struct Mol Biol (2011) 1.61

Crystal structure of species D adenovirus fiber knobs and their sialic acid binding sites. J Virol (2004) 1.60

Structure of the measles virus hemagglutinin bound to the CD46 receptor. Nat Struct Mol Biol (2009) 1.58

Differential downregulation of CD46 by measles virus strains. J Virol (1995) 1.57

Measles virus for cancer therapy. Curr Top Microbiol Immunol (2009) 1.56

Receptor (SLAM [CD150]) recognition and the V protein sustain swift lymphocyte-based invasion of mucosal tissue and lymphatic organs by a morbillivirus. J Virol (2006) 1.54

Virus entry is a major determinant of cell tropism of Edmonston and wild-type strains of measles virus as revealed by vesicular stomatitis virus pseudotypes bearing their envelope proteins. J Virol (2000) 1.52

Transgenic mice expressing human measles virus (MV) receptor CD46 provide cells exhibiting different permissivities to MV infections. J Virol (1996) 1.51

Cell entry by measles virus: long hybrid receptors uncouple binding from membrane fusion. J Virol (1996) 1.51

Probing the spatial organization of measles virus fusion complexes. J Virol (2009) 1.50

Measles virus attenuation associated with transcriptional impediment and a few amino acid changes in the polymerase and accessory proteins. J Virol (1998) 1.50

Physical association of moesin and CD46 as a receptor complex for measles virus. J Virol (1995) 1.48

Binding of measles virus to membrane cofactor protein (CD46): importance of disulfide bonds and N-glycans for the receptor function. J Virol (1994) 1.46

V domain of human SLAM (CDw150) is essential for its function as a measles virus receptor. J Virol (2001) 1.45

Recombinant measles viruses efficiently entering cells through targeted receptors. J Virol (2000) 1.44

Dynamics of viral RNA synthesis during measles virus infection. J Virol (2005) 1.44

The v-erbB oncogene confers enhanced cellular susceptibility to reovirus infection. J Virol (1996) 1.43

Artificial mutations and natural variations in the CD46 molecules from human and monkey cells define regions important for measles virus binding. J Virol (1997) 1.41

The association of CD46, SLAM and CD209 cellular receptor gene SNPs with variations in measles vaccine-induced immune responses: a replication study and examination of novel polymorphisms. Hum Hered (2011) 1.40

A human lung carcinoma cell line supports efficient measles virus growth and syncytium formation via a SLAM- and CD46-independent mechanism. J Virol (2007) 1.39

The H gene of rodent brain-adapted measles virus confers neurovirulence to the Edmonston vaccine strain. J Virol (1999) 1.38

Interaction between echovirus 7 and its receptor, decay-accelerating factor (CD55): evidence for a secondary cellular factor in A-particle formation. J Virol (1997) 1.38

Characterization of a region of the measles virus hemagglutinin sufficient for its dimerization. J Virol (2000) 1.38

Measles virus spread between neurons requires cell contact but not CD46 expression, syncytium formation, or extracellular virus production. J Virol (2000) 1.35

In vivo tropism of attenuated and pathogenic measles virus expressing green fluorescent protein in macaques. J Virol (2010) 1.35

Clinical testing of engineered oncolytic measles virus strains in the treatment of cancer: an overview. Curr Opin Mol Ther (2009) 1.35

Immunoglobulin g antibody-mediated enhancement of measles virus infection can bypass the protective antiviral immune response. J Virol (2006) 1.35

Paramyxoviruses: different receptors - different mechanisms of fusion. Trends Microbiol (2008) 1.34

Characterization of the echovirus 7 receptor: domains of CD55 critical for virus binding. J Virol (1995) 1.34

Structural and mechanistic studies of measles virus illuminate paramyxovirus entry. PLoS Pathog (2011) 1.34

A recombinant measles virus expressing hepatitis B virus surface antigen induces humoral immune responses in genetically modified mice. J Virol (1999) 1.33

Measles virus matrix protein specifies apical virus release and glycoprotein sorting in epithelial cells. EMBO J (2000) 1.33

Roles of macrophages in measles virus infection of genetically modified mice. J Virol (2001) 1.33

Measles virus infection of alveolar macrophages and dendritic cells precedes spread to lymphatic organs in transgenic mice expressing human signaling lymphocytic activation molecule (SLAM, CD150). J Virol (2009) 1.32

Measles virus targets DC-SIGN to enhance dendritic cell infection. J Virol (2006) 1.32

Human herpesvirus 6 variant A but not variant B induces fusion from without in a variety of human cells through a human herpesvirus 6 entry receptor, CD46. J Virol (2002) 1.31

Single-chain antibody displayed on a recombinant measles virus confers entry through the tumor-associated carcinoembryonic antigen. J Virol (2001) 1.31

Immune response-mediated protection of adult but not neonatal mice from neuron-restricted measles virus infection and central nervous system disease. J Virol (1999) 1.30

Measles virus (MV) hemagglutinin: evidence that attachment sites for MV receptors SLAM and CD46 overlap on the globular head. J Virol (2004) 1.29

Functional and structural interactions between measles virus hemagglutinin and CD46. J Virol (1995) 1.29

Dynamic interaction of the measles virus hemagglutinin with its receptor signaling lymphocytic activation molecule (SLAM, CD150). J Biol Chem (2008) 1.29

A molecularly cloned Schwarz strain of measles virus vaccine induces strong immune responses in macaques and transgenic mice. J Virol (2003) 1.28

Translational inhibition and increased interferon induction in cells infected with C protein-deficient measles virus. J Virol (2006) 1.28

Measles virus-induced suppression of immune responses. Immunol Rev (2010) 1.27

CD9, a tetraspan transmembrane protein, renders cells susceptible to canine distemper virus. J Virol (1997) 1.26

A recombinant measles vaccine virus expressing wild-type glycoproteins: consequences for viral spread and cell tropism. J Virol (1999) 1.25

Measles virus selectively blind to signaling lymphocytic activation molecule (SLAM; CD150) is attenuated and induces strong adaptive immune responses in rhesus monkeys. J Virol (2010) 1.25

Engineered measles virus as a novel oncolytic therapy against prostate cancer. Prostate (2009) 1.25

Interleukin-13 displaying retargeted oncolytic measles virus strains have significant activity against gliomas with improved specificity. Mol Ther (2008) 1.24

Nonnucleoside inhibitor of measles virus RNA-dependent RNA polymerase complex activity. Antimicrob Agents Chemother (2007) 1.24

Efficiency of measles virus entry and dissemination through different receptors. J Virol (2002) 1.22

Noninvasive imaging and radiovirotherapy of prostate cancer using an oncolytic measles virus expressing the sodium iodide symporter. Mol Ther (2009) 1.22

Role of sialic acid-containing molecules in paramyxovirus entry into the host cell: a minireview. Glycoconj J (2006) 1.21

Structure of the extracellular portion of CD46 provides insights into its interactions with complement proteins and pathogens. PLoS Pathog (2010) 1.20

In vitro and in vivo infection of neural cells by a recombinant measles virus expressing enhanced green fluorescent protein. J Virol (2000) 1.20

Articles cited by this

The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature (1985) 30.47

The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell (1986) 22.26

T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature (1985) 21.57

Cellular receptor for poliovirus: molecular cloning, nucleotide sequence, and expression of a new member of the immunoglobulin superfamily. Cell (1989) 9.82

The enzymatic iodination of the red cell membrane. J Cell Biol (1972) 8.62

The major human rhinovirus receptor is ICAM-1. Cell (1989) 7.81

Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2. Proc Natl Acad Sci U S A (1984) 6.62

Membrane cofactor protein (MCP or CD46): newest member of the regulators of complement activation gene cluster. Annu Rev Immunol (1991) 4.27

Identification and characterization of the Epstein-Barr virus receptor on human B lymphocytes and its relationship to the C3d complement receptor (CR2). J Virol (1985) 3.76

cDNA cloning reveals that the major group rhinovirus receptor on HeLa cells is intercellular adhesion molecule 1. Proc Natl Acad Sci U S A (1989) 3.09

Measles virus: both the haemagglutinin and fusion glycoproteins are required for fusion. J Gen Virol (1991) 2.90

Molecular cloning and chromosomal localization of human membrane cofactor protein (MCP). Evidence for inclusion in the multigene family of complement-regulatory proteins. J Exp Med (1988) 2.75

Vaccines for the Third World. Nature (1989) 2.58

An in situ transgenic enzyme marker for the midgestation mouse embryo and the visualization of inner cell mass clones during early organogenesis. Development (1989) 2.55

Correlation between epitopes on hemagglutinin of measles virus and biological activities: passive protection by monoclonal antibodies is related to their hemagglutination inhibiting activity. Virology (1985) 2.25

Measles virus haemagglutinin induces down-regulation of gp57/67, a molecule involved in virus binding. J Gen Virol (1993) 2.07

Phospholipid-anchored and transmembrane versions of either decay-accelerating factor or membrane cofactor protein show equal efficiency in protection from complement-mediated cell damage. J Exp Med (1991) 1.90

Tissue-specific and allelic expression of the complement regulator CD46 is controlled by alternative splicing. Eur J Immunol (1992) 1.64

A monoclonal antibody recognizes a human cell surface glycoprotein involved in measles virus binding. J Gen Virol (1992) 1.58

Binding of human immunodeficiency virus type-1 to follicular dendritic cells in vitro is complement dependent. J Immunol (1993) 1.45

The human cell-surface glycoproteins HuLy-m5, membrane co-factor protein (MCP) of the complement system, and trophoblast leucocyte-common (TLX) antigen, are CD46. Immunology (1990) 1.45

Construction of vaccinia virus recombinants expressing several measles virus proteins and analysis of their efficacy in vaccination of mice. J Gen Virol (1992) 1.44

Complement mediates human immunodeficiency virus type 1 infection of a human T cell line in a CD4- and antibody-independent fashion. J Exp Med (1991) 1.44

Characterization of a cDNA clone coding for human testis membrane cofactor protein (MCP, CD46). Mol Reprod Dev (1993) 1.13

Localization and characterization of the acrosomal antigen recognized by GB24 on human spermatozoa. Mol Reprod Dev (1990) 1.11

Cytosolic targeting of hen egg lysozyme gives rise to a short-lived protein presented by class I but not class II major histocompatibility complex molecules. Eur J Immunol (1991) 1.07

Articles by these authors

Tyrosine phosphorylation of I kappa B-alpha activates NF-kappa B without proteolytic degradation of I kappa B-alpha. Cell (1996) 3.00

Characterization of novel safe lentiviral vectors derived from simian immunodeficiency virus (SIVmac251) that efficiently transduce mature human dendritic cells. Gene Ther (2000) 2.95

Hepatitis C virus infection protein network. Mol Syst Biol (2008) 2.91

Measles virus suppresses cell-mediated immunity by interfering with the survival and functions of dendritic and T cells. J Exp Med (1997) 2.90

Use of MTT colorimetric assay to measure cell activation. J Immunol Methods (1986) 2.41

Measles virus structural components are enriched into lipid raft microdomains: a potential cellular location for virus assembly. J Virol (2000) 2.40

Correlation between epitopes on hemagglutinin of measles virus and biological activities: passive protection by monoclonal antibodies is related to their hemagglutination inhibiting activity. Virology (1985) 2.25

Identification of two amino acids in the hemagglutinin glycoprotein of measles virus (MV) that govern hemadsorption, HeLa cell fusion, and CD46 downregulation: phenotypic markers that differentiate vaccine and wild-type MV strains. J Virol (1996) 2.19

Mild clinical expression of myasthenia gravis associated with autoimmune thyroid diseases. J Clin Endocrinol Metab (1997) 2.11

Nipah virus: vaccination and passive protection studies in a hamster model. J Virol (2004) 2.09

Measles virus haemagglutinin induces down-regulation of gp57/67, a molecule involved in virus binding. J Gen Virol (1993) 2.07

Intraarterial injection of muscle-derived CD34(+)Sca-1(+) stem cells restores dystrophin in mdx mice. J Cell Biol (2001) 2.06

Characterization of a natural inhibitor of the insulin receptor tyrosine kinase: cDNA cloning, purification, and anti-mitogenic activity. Cell (1989) 1.96

Type 1 fiber abnormalities in skeletal muscle of patients with hypertrophic and dilated cardiomyopathy: evidence of subclinical myogenic myopathy. J Am Coll Cardiol (1989) 1.76

Measles virus assembly within membrane rafts. J Virol (2000) 1.65

Measles virus glycoproteins: studies on the structure and interaction of the haemagglutinin and fusion proteins. J Gen Virol (1993) 1.64

A new method for monitoring body fluid variation by bioimpedance analysis: the RXc graph. Kidney Int (1994) 1.60

A monoclonal antibody recognizes a human cell surface glycoprotein involved in measles virus binding. J Gen Virol (1992) 1.58

Replication of vesicular stomatitis virus: characterization of the virus-induced RNA. J Gen Virol (1971) 1.56

Working principles in the immune system implied by the "peptidic self" model. Proc Natl Acad Sci U S A (1987) 1.55

Transgenic mice expressing human measles virus (MV) receptor CD46 provide cells exhibiting different permissivities to MV infections. J Virol (1996) 1.51

Cell entry by measles virus: long hybrid receptors uncouple binding from membrane fusion. J Virol (1996) 1.51

Characterization and function of T cell Fc gamma receptor. Immunol Rev (1981) 1.50

Receptor-mediated phosphorylation of the hepatic insulin receptor: evidence that the Mr 95,000 receptor subunit is its own kinase. Proc Natl Acad Sci U S A (1983) 1.49

Intensity modulated proton therapy: a clinical example. Med Phys (2001) 1.49

Surgical treatment of tuberculous spondylodiscitis. Eur Rev Med Pharmacol Sci (2012) 1.49

Cytosine deaminase/5-fluorocytosine-based vaccination against liver tumors: evidence of distant bystander effect. J Natl Cancer Inst (1999) 1.48

Measles virus induces abnormal differentiation of CD40 ligand-activated human dendritic cells. J Immunol (2000) 1.47

Antibody prophylaxis and therapy against Nipah virus infection in hamsters. J Virol (2006) 1.47

Hepatocytes induce functional activation of naive CD8+ T lymphocytes but fail to promote survival. Eur J Immunol (1998) 1.47

T-cell hybrids bear Fcgamma receptors and secrete suppressor immunoglobulin binding factor. Nature (1979) 1.47

Measles virus induces functional TRAIL production by human dendritic cells. J Virol (2000) 1.43

Cutting edge: CD46, a new costimulatory molecule for T cells, that induces p120CBL and LAT phosphorylation. J Immunol (2000) 1.41

Nonstructural C protein is required for efficient measles virus replication in human peripheral blood cells. J Virol (1999) 1.37

CD40 signaling in human dendritic cells is initiated within membrane rafts. EMBO J (2000) 1.37

Transplantation potential of peripheral whole blood primed by VACOP-B chemotherapy plus filgrastim (r-metHuG-CSF) in patients with aggressive non-Hodgkin's lumphoma. J Hematother Stem Cell Res (2000) 1.37

Fusion glycoprotein of measles virus: nucleotide sequence of the gene and comparison with other paramyxoviruses. J Gen Virol (1987) 1.36

Mechanism of measles virus-induced suppression of inflammatory immune responses. Immunity (2001) 1.36

Identification of several different lineages of measles virus. J Gen Virol (1991) 1.35

Measles virus haemagglutinin gene: cloning, complete nucleotide sequence analysis and expression in COS cells. J Gen Virol (1986) 1.33

Mapping of the primary binding site of measles virus to its receptor CD46. J Biol Chem (1997) 1.32

Measles virus strains circulating in Central and West Africa: Geographical distribution of two B3 genotypes. J Med Virol (2002) 1.29

Signal transduction involved in MCP-1-mediated monocytic transendothelial migration. Blood (2001) 1.28

Saccharomyces boulardii preserves the barrier function and modulates the signal transduction pathway induced in enteropathogenic Escherichia coli-infected T84 cells. Infect Immun (2000) 1.28

Elastofibroma dorsi: 8 case reports and a literature review. J Orthop Traumatol (2008) 1.26

Surface structure of foot-and-mouth disease virus. J Gen Virol (1969) 1.25

CD46 (membrane cofactor protein) associates with multiple beta1 integrins and tetraspans. Eur J Immunol (2000) 1.25

Bivariate normal values of the bioelectrical impedance vector in adult and elderly populations. Am J Clin Nutr (1995) 1.25

A hybrid approach to EMG pattern analysis for classification of arm movements using statistical and fuzzy techniques. Med Eng Phys (1999) 1.24

Expression of HLA-DR antigens at the surface of mouse L cells co-transfected with cloned human genes. Nature (1983) 1.22

CD46/CD3 costimulation induces morphological changes of human T cells and activation of Vav, Rac, and extracellular signal-regulated kinase mitogen-activated protein kinase. J Immunol (2001) 1.22

EFNS guidelines on cognitive rehabilitation: report of an EFNS task force. Eur J Neurol (2005) 1.17

Is CD46 the cellular receptor for measles virus? Virus Res (1997) 1.17

Replacement of insulin receptor tyrosine residues 1162 and 1163 does not alter the mitogenic effect of the hormone. Proc Natl Acad Sci U S A (1988) 1.16

Implication of mitogen-activated protein kinases in T84 cell responses to enteropathogenic Escherichia coli infection. Infect Immun (2001) 1.16

Consequences of Fas-mediated human dendritic cell apoptosis induced by measles virus. J Virol (2000) 1.16

Neoadjuvant chemotherapy, surgery, and postoperative radiation therapy for invasive thymoma. Cancer (1991) 1.15

Cell-to-cell contact via measles virus haemagglutinin-CD46 interaction triggers CD46 downregulation. J Gen Virol (1995) 1.15

Antigenic analysis of African measles virus field isolates: identification and localisation of one conserved and two variable epitope sites on the NP protein. Virus Res (1988) 1.15

Monoclonal antibodies against measles virus. J Gen Virol (1981) 1.14

Characterization of a cDNA clone coding for human testis membrane cofactor protein (MCP, CD46). Mol Reprod Dev (1993) 1.13

Serological and virological characterization of clinically diagnosed cases of measles in suburban Khartoum. J Clin Microbiol (2000) 1.13

Thrombin and thrombin receptor agonist peptide induce early events of T cell activation and synergize with TCR cross-linking for CD69 expression and interleukin 2 production. J Biol Chem (1994) 1.13

Thrombin and trypsin-induced Ca(2+) mobilization in human T cell lines through interaction with different protease-activated receptors. FASEB J (1996) 1.13

Liposomes as a tool to study the role of membrane presentation in the immunogenicity of a MuLV-related tumor antigen. J Immunol (1983) 1.12

Localization and characterization of the acrosomal antigen recognized by GB24 on human spermatozoa. Mol Reprod Dev (1990) 1.11

Mucosal DNA vaccine immunization against measles with a highly attenuated Shigella flexneri vector. J Immunol (1999) 1.10

Measles virus receptor properties are shared by several CD46 isoforms differing in extracellular regions and cytoplasmic tails. J Gen Virol (1994) 1.10

Escherichia coli cytotoxic necrotizing factor-1 (CNF-1) increases the adherence to epithelia and the oxidative burst of human polymorphonuclear leukocytes but decreases bacteria phagocytosis. J Leukoc Biol (2000) 1.09

Measles virus and dendritic cell functions: how specific response cohabits with immunosuppression. Curr Top Microbiol Immunol (2003) 1.09

Signal transduction pathways involved in soluble fractalkine-induced monocytic cell adhesion. Blood (2001) 1.09

Escherichia coli cytotoxic necrotizing factor 1 effaces microvilli and decreases transmigration of polymorphonuclear leukocytes in intestinal T84 epithelial cell monolayers. Infect Immun (1998) 1.09

Octamerization enables soluble CD46 receptor to neutralize measles virus in vitro and in vivo. J Virol (2000) 1.08

Cytosolic targeting of hen egg lysozyme gives rise to a short-lived protein presented by class I but not class II major histocompatibility complex molecules. Eur J Immunol (1991) 1.07

CD46-mediated measles virus entry: a first key to host-range specificity. Trends Microbiol (1995) 1.06

Role of CD46 in measles virus infection in CD46 transgenic mice. Virology (1998) 1.05

Sustained polymorphonuclear leukocyte transmigration induces apoptosis in T84 intestinal epithelial cells. J Cell Biol (2000) 1.05

Glycosyl-phosphatidylinositol-anchored and transmembrane forms of CD46 display similar measles virus receptor properties: virus binding, fusion, and replication; down-regulation by hemagglutinin; and virus uptake and endocytosis for antigen presentation by major histocompatibility complex class II molecules. J Virol (1994) 1.05

Resection of parosteal osteosarcoma of the distal part of the femur: an original reconstruction technique with cement and plate. Sarcoma (2008) 1.05

ViralORFeome: an integrated database to generate a versatile collection of viral ORFs. Nucleic Acids Res (2009) 1.04

Death by neglect as a deletional mechanism of peripheral tolerance. Int Immunol (1999) 1.03

Nature of the inactivating action of trypsin on foot-and-mouth disease virus. J Gen Virol (1967) 1.03

Interactions between the ectodomains of haemagglutinin and CD46 as a primary step in measles virus entry. J Gen Virol (1996) 1.03

Efficient major histocompatibility complex class II-restricted presentation of measles virus relies on hemagglutinin-mediated targeting to its cellular receptor human CD46 expressed by murine B cells. J Exp Med (1994) 1.02

Extracellular ATP and UTP control the generation of reactive oxygen intermediates in human macrophages through the opening of a charybdotoxin-sensitive Ca2+-dependent K+ channel. J Immunol (1997) 1.01

Measles virus nucleocapsid protein binds to FcgammaRII and inhibits human B cell antibody production. J Exp Med (1997) 1.01

Management of bowel obstruction in advanced and terminal cancer patients. Ann Oncol (1993) 1.01